======= EPN1 ======= == Gene Information == * **Official Symbol**: EPN1 * **Official Name**: epsin 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=29924|29924]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y6I3|Q9Y6I3]] * **Interactions**: [[https://thebiogrid.org/search.php?search=EPN1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20EPN1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607262|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Binds to membranes enriched in phosphatidylinositol 4,5- bisphosphate (PtdIns(4,5)P2). Modifies membrane curvature and facilitates the formation of clathrin-coated invaginations (By similarity). Regulates receptor-mediated endocytosis. {ECO:0000250, ECO:0000269|PubMed:10557078}. |ENTH| |negative regulation of sprouting angiogenesis| |negative regulation of epidermal growth factor receptor signaling pathway| |negative regulation of ERBB signaling pathway| |clathrin-coated pit| |regulation of sprouting angiogenesis| |regulation of epidermal growth factor receptor signaling pathway| |regulation of ERBB signaling pathway| |negative regulation of angiogenesis| |negative regulation of blood vessel morphogenesis| |negative regulation of vasculature development| |Notch signaling pathway| |lipid binding| |female pregnancy| |multi-multicellular organism process| |regulation of angiogenesis| |regulation of vasculature development| |in utero embryonic development| |embryonic organ development| |endocytosis| |chordate embryonic development| |embryo development ending in birth or egg hatching| |import into cell| |membrane organization| |negative regulation of developmental process| |embryo development| |multi-organism reproductive process| |regulation of anatomical structure morphogenesis| |negative regulation of multicellular organismal process| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |reproductive process| |reproduction| |negative regulation of response to stimulus| |vesicle-mediated transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|-2.52| |[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-2.41| |[[:results:exp501|Methotrexate 0.01μM R08 exp501]]|-2.41| |[[:results:exp227|Cryptotanshinone 12μM R05 exp227]]|-2.14| |[[:results:exp214|2-Deoxy-D-glucose 800μM R05 exp214]]|-1.87| |[[:results:exp321|ABT-702 5μM plus Deferoxamine 11μM R07 exp321]]|-1.87| |[[:results:exp240|Pyridostatin 4μM R05 exp240]]|-1.83| |[[:results:exp275|Citral 75μM R06 exp275]]|-1.82| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|-1.79| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.79| |[[:results:exp122|Golgicide-A 4μM R03 exp122]]|-1.77| |[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.74| |[[:results:exp307|Rapamycin 2μM plus Cyclosporin-A 3μM R07 exp307]]|-1.73| |[[:results:exp329|Hydroxyurea 100μM R07 exp329]]|-1.7| |[[:results:exp301|VER-155008 3.9μM R06 exp301]]|1.75| |[[:results:exp492|iCRT14 30μM R08 exp492]]|2.17| No correlation found to any other genes in chemogenomics. Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 15851 * **Expression level (log2 read counts)**: 6.55 {{:chemogenomics:nalm6 dist.png?nolink |}}